Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Two Part, Multi Centre, Randomized, Placebo Controlled, Double Blind Study of TRK-170 in Crohn's Disease
2011-000854-44Phase 2Completed
- Sponsor
- Toray Industries
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing TRK-170 with Placebo (2 arms). Primary endpoint: Primary endpoint Part A. Started Mar 2011; status: completed.
02
Drugs
TRK-170
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2011-000854-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000854-44.